[Candesartan reduces the risk of mortality and recurrence of chronic heart failure. Important results from the CHARM study]

MeSH terms

• Angiotensin II Type 2 Receptor Blockers*
• Antihypertensive Agents / therapeutic use*
• Benzimidazoles / therapeutic use*
• Biphenyl Compounds
• Heart Failure / drug therapy*
• Heart Failure / mortality
• Humans
• Randomized Controlled Trials as Topic
• Recurrence
• Risk Factors
• Tetrazoles / therapeutic use*